'Absolute Robbery': Gilead Announces $3,120 Price Tag for Covid-19 Drug Developed With $70 Million in Taxpayer Support

Quicklink Submitted By Susan Lee Schwartz No comments

Become a Fan
(23 fans)

"Taxpayers provided funding for the development of this drug. Now Gilead is price-gouging off it during a pandemic. Consumer advocates reacted with disgust Monday to an announcement by Gilead Sciences that it will charge U.S. hospitals around $3,120 per privately insured patient for a treatment course of remdesivir, a drug which has proven modestly effective at speeding Covid-19 recovery times.Beyond disgusting," said Sen. Bernie Sanders.

Read the rest of the story HERE:

At www.commondreams.org

Rate It | View Ratings

Susan Lee Schwartz Social Media Pages:

I began teaching in 1963,; Ba and BS in Education -Brooklyn College. I have the equivalent of 2 additional Master's, mainly in Literacy Studies and Graphic Design. I was the only seventh grade teacher of English from 1990 -1999 at East Side (more...)

Related Topic(s): Drug Companies- Marketing; Funding; Pandemic; Price Controls, Add Tags

Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Contact Author

Contact Editor

View Authors' Articles

OpEdNews ~~depends upon~~ can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.

To View Comments or Join the Conversation: